Blog

Erin Polak: Barriers to Early Cancer Detection at ACS CAN National Forum

Erin Polak/LinkedIn

May 16, 2025, 16:47

Erin Polak: Barriers to Early Cancer Detection at ACS CAN National Forum

Erin Polak, Senior Vice President of Government Affairs, Policy, and Alliance Development at GRAIL, shared a post on LinkedIn:

“Kudos to the American Cancer Society Cancer Action Network (ACS CAN) for today’s fantastic National Forum on the Future of Healthcare which focused on breaking down barriers to cancer screening and early detection. I was grateful for the opportunity to discuss access barriers to multi-cancer early detection testing and to learn from patients and experts about how we can work together to bend the cancer suffering curve.

The status quo is simply unacceptable. We need to improve screening rates (a new ACS CAN survey found that 31% of adults have been more than one year behind on cancer screenings) and leverage innovation to detect more cancers earlier, when treatment is more effective and less costly.

I left the discussion energized and grateful for Lisa A. Lacasse, Pam Traxel, and the ACS CAN team for their leadership identifying and tackling the critical policy questions impacting patients across the cancer care continuum.”

Lisa A. Lacasse, President of the American Cancer Society Cancer Action Network (ACS CAN), shared this post, adding:

“Thanks so much, Erin Polak, for contributing your brilliant perspectives for this critical discussion. Appreciate your partnership as we work to change the future of early cancer detection. Much to do together on behalf of our collective desire to reduce the cancer burden nationwide for everyone.”

Read further.

Erin Polak emphasized the urgency of addressing delays in cancer screening and highlighted the potential of multi-cancer early detection tests to transform outcomes. She praised the ACS CAN forum for fostering collaboration across policy and patient communities.

More posts featuring Lisa A. Lacasse.

ACS CAN American Cancer Society Cancer Action Network cancer cancer screening early detection Erin Polak Future of Healthcare Lisa A. Lacasse OncoDaily Oncology Pam Traxel

DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer

FDA Approves Belzutifan (Welireg) for Advanced Pheochromocytoma and Paraganglioma: Results of LITESPARK-015 Trial

New World Cancer Declaration 2025–2035 by UICC

Agenus Bets Big on Botensilimab

Carlos Rodriguez-Galindo: Childhood cancer has long been overlooked in global strategies - It is time to change that